Avacta Group Plc (LON:AVCT – Get Free Report) shares rose 13.2% during mid-day trading on Monday . The company traded as high as GBX 59.60 ($0.74) and last traded at GBX 58.93 ($0.74). Approximately 1,319,979 shares were traded during trading, an increase of 11% from the average daily volume of 1,189,764 shares. The stock had previously closed at GBX 52.05 ($0.65).
Avacta Group Price Performance
The company has a market cap of £193.12 million, a PE ratio of -598.89 and a beta of 1.12. The business’s 50 day moving average price is GBX 48.62 and its 200-day moving average price is GBX 58.78. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 63.54.
About Avacta Group
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- Consumer Discretionary Stocks Explained
- 3 Innovative Small-Cap Tech Stocks: Time to Buy, Sell, or Hold?
- Ride Out The Recession With These Dividend Kings
- Top 3 Stocks Goldman Sachs Predicts Will Dominate 2025
- Buy P&G Now, Before It Sets A New All-Time High
- Top 2 Auto Maintenance Stocks Gearing Up for 2025
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
